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non-adherent cells were plated (1 £ 105 ml21) and cultured for 6 days. Unactivated
macrophages were stimulated with L. monocytogenes using a multiplicity of infection of 20,
whereas macrophages activated with IFN-g (400 U ml21) for 16 h were stimulated with
LPS. Nuclear extracts (3 mg) were incubated with a 32P-labelled oligonucleotide probe
derived from the major histocompatibility complex (MHC) class II NF-kB consensus-
binding site, and analysed by EMSA.
Transient transfection and luciferase analysis
Human embryonic kidney (293T) cells were plated in 6-well plates at 2.5 £ 105 cells per
well. Cells were stimulated by transfection with plasmid pCMV (cytomegalovirus) human
NOD1 (10 ng) or pCMV murine CD4-TLR4 (10 ng). Stimulated cells were inhibited by
co-transfection with pCMV human RIP2-DN (1–434), pcDNA3 murine MyD88-DN,
pCiNeo murine IRAK-DN, or pCMV IkB-DA, as indicated (in ng). All transfections were
performed with a luciferase reporter plasmid containing two kB binding sites (20 ng) and
pCMV-LacZ (40 ng). Luciferase activity was measured and normalized to beta-
galactosidase activity.
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The immune system consists of two evolutionarily different but
closely related responses, innate immunity and adaptive immu-
nity. Each of these responses has characteristic receptors—Toll-
like receptors (TLRs) for innate immunity and antigen-specific
receptors for adaptive immunity. Here we show that the caspase
recruitment domain (CARD)-containing serine/threonine kinase
Rip2 (also known as RICK, CARDIAK, CCK and Ripk2)1 – 4
transduces signals from receptors of both immune responses.
Rip2 was recruited to TLR2 signalling complexes after ligand
stimulation. Moreover, cytokine production in Rip2-deficient
cells was reduced on stimulation of TLRs with lipopolysacchar-
ide, peptidoglycan and double-stranded RNA, but not with
bacterial DNA, indicating that Rip2 is downstream of TLR2/3/4
but not TLR9. Rip2-deficient cells were also hyporesponsive to
signalling through interleukin (IL)-1 and IL-18 receptors, and
deficient for signalling through Nod proteins—molecules also
implicated in the innate immune response. Furthermore, Rip2-
deficient T cells showed severely reduced NF-kB activation, IL-2
production and proliferation on T-cell-receptor (TCR) engage-
ment, and impaired differentiation to T-helper subtype 1 (TH1)
cells, indicating that Rip2 is required for optimal TCR signalling
and T-cell differentiation. Rip2 is therefore a signal transducer
and integrator of signals for both the innate and adaptive
immune systems.
Rip2 is a serine/threonine kinase1 – 4 that carries a CARD at its
carboxy terminus, and shares sequence similarity with a serine/
threonine kinase, Rip, which is essential for NF-kB activation
through the tumour-necrosis factor (TNF) receptor5. In vitro
studies have shown that Rip2 can associate with a variety of other
CARD-containing molecules through CARD – CARD inter-
actions1 – 3. Moreover, overexpression of Rip2 causes activation of
NF-kB and Jun amino-terminal kinase (JNK)1 – 4. NF-kB activation
by Rip2 is inhibited by dominant negative TRAF6 (ref. 4), a
signalling molecule that is downstream of TLRs. Furthermore, we
found that expression of Rip2 was induced in macrophages on
stimulation with lipopolysaccharide (LPS) (Fig. 1a, b). These
observations led us to consider the possibility that Rip2 is involved
in signalling in the innate immune system. To assess the physio-
logical role of Rip2 in signalling in the innate immune system, we
generated Rip2-deficient mice by homologous recombination of
embryonic stem cells. A gene-targeting construct was generated to
replace the two exons coding for murine Rip2 with a neomycin-
resistance gene (neor) (Fig. 1c). Homologous recombination in
embryonic stem cells was confirmed by Southern blot analysis
(Fig. 1d), and the absence of Rip2 expression in homozygous animals
was confirmed by western blot (Fig. 1e). Rip2-deficient mice were
born in the expected mendelian ratio, and showed no gross devel-
opmental abnormalities and no abnormal composition of lympho-
cytes as determined by flow cytometry (data not shown).
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TLRs can recognize specific pathogen-associated molecular pat-
terns (PAMPs) such as LPS6, lipoteichoic acid (LTA)7, peptidogly-
can (PGN)7, CpG-containing DNA8, or double-stranded RNA9. To
test whether Rip2 is involved in TLR signalling, macrophages of
Rip22/2 mice were stimulated with various PAMPs, and cytokine/
chemokine production was assessed by enzyme-linked immuno-
sorbent assay (ELISA). Production of the inflammatory cytokines
IL-6 and TNF-a, and the chemokine IP10, was severely reduced in
macrophages of Rip22/2 mice on stimulation with LPS and LTA
(both of which are ligands for TLR4), or PGN (which is a ligand for
TLR2) (Fig. 2a). There was no defect in cytokine/chemokine
production after stimulation with CpG DNA (a ligand for TLR9),
indicating that Rip2 is involved in TLR4 and TLR2 but not TLR9
signalling. Production of IL-6 is also reduced in Rip22/2 embryonic
fibroblasts on stimulation with double-stranded RNA, poly(IC) (a
ligand for TLR3) and LPS in a dose- and time-dependent manner
(Fig. 2c). These results indicate that Rip2 is required for normal
levels of signalling through some, but not all, TLRs. To assess the
response to a live pathogen, macrophages of Rip22/2 mice were
infected with Listeria monocytogenes, and the levels of IL-6 and
TNF-a were measured by ELISA. Macrophages of Rip22/2 mice
were compromised in their ability to produce these cytokines,
further supporting the involvement of this kinase in the innate
immune response (Fig. 2b and data not shown). To examine the
mechanism of activation of Rip2 in macrophages infected with
L. monocytogenes, in particular to determine whether stimulation of
the innate immune response by Listeria occurs at the cell surface or
intracellularly, cytochalasin D was added to cell cultures at various
concentrations, as it blocks Listeria internalization10. IL-6 pro-
duction in response to Listeria infection was not altered even at
high concentrations of cytochalasin D, and in all cases was reduced
in Rip22/2 cells (Fig. 2b). Thus, attachment of bacteria to the cell
surface is sufficient to activate macrophages, and the reduced
cytokine production in Rip22/2 cells is due to defective signalling
from cell-surface receptors. In vivo response to LPS by Rip2-
deficient mice was assessed by endotoxin shock experiments using
intraperitoneal injection of LPS. Rip2-deficient mice were more
resistant to LPS than wild-type mice (Fig. 2d), suggesting the
importance of this molecule in LPS response in vivo.
Mature IL-1b can be produced through cleavage of pro-IL-1b by
active caspase-1. Previous in vitro studies have suggested that Rip2
binds and activates pro-caspase-1, thereby generating IL-1b3,11.
Notably, macrophages of Rip22/2 mice exhibited no reduction in
IL-1b production when cells were stimulated with LPS, CpG DNA
and peptidoglycan for 3 h (Supplementary Information),
suggesting that Rip2 is not involved in caspase-1 activation down-
stream of TLRs, or alternatively that there is another redundant
mechanism.
TLR signalling requires the formation of multiprotein signalling
complexes, which include the serine/threonine kinase IRAK and the
adapter molecules MyD88 and TRAF6, resulting in the activation of
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Figure 1 Expression of Rip2 in macrophages and targeted disruption of the mouse Rip2
gene. a, b, Northern and western blot analysis for Rip2 expression in macrophages
stimulated with 10 ng ml21 LPS for the indicated times. HPRT, hypoxanthine guanine
phosphoribosyltransferase. c, Diagram of the Rip2 locus, the targeting vector and the
targeted allele. Filled boxes denote exons. Restriction enzyme sites are indicated (S, SacI;
EV, EcoRV; X, XbaI; A, ApaI). TK, thymidine kinase. d, Southern blot analysis of SacI-
digested genomic DNA identifies mice of all three expected genotypes. e, Western blot




























































































































































Figure 2 Impaired TLR responses in Rip2-deficient cells. a, Production of IL-6, TNF-a
and IP10 by Rip22/2 macrophages derived from bone marrow, stimulated with LPS
(10 ng ml21), LTA (10 mg ml21), PGN (10 mg ml21), CpG oligonucleotide DNA (CpG,
10 mM), and medium alone (MED) for 6 h. ND, not detected. b, Production of IL-6 by
Rip22/2 macrophages infected with L. monocyotogenes and cultured for the indicated
period (left), or cultured for 6 h in the presence of the indicated concentrations of
cytochalasin D (right). c, Production of IL-6 by Rip22/2 fibroblasts stimulated with poly(IC)
or LPS with indicated dose for 24 h (left), or stimulated with 100 mg ml21 poly(IC) (middle)
or 10 ng ml21 LPS (right) for indicated periods. d, Survival curve of wild-type and Rip22/2
mice after endotoxin shock. LPS (16.7 mg kg21 body weight) was injected
intraperitoneally into wild-type and Rip22/2 mice. Viability was determined every 3 h for
the first 36 h, followed by every 12 h. There was no incremental death after 80 h. P-values
were determined by the Mantel–Cox test. Experiments were performed with triplicates and
were repeated 6 (a, IL-6), 3 (a, TNF-a/IP10) and 2 (b, c) times, with equivalent results.
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NF-kB and the mitogen-activated protein (MAP) kinases JNK, p38
and ERK1/2 (refs 12, 13). We therefore studied activation of
these molecules in macrophages of Rip22/2 mice by examining
their phosphorylation state. LPS-stimulated Rip22/2 macrophages
showed reduced phosphorylation levels of p38, IkBa, ERK and JNK,
and reduced degradation of IkBa (Fig. 3a), indicating altered
signalling downstream from TLR4. This reduced signalling was
not due to changes in the expression levels of MyD88, IRAK or
TRAF6, as western blot analysis for these proteins showed no
difference between wild-type and Rip22/2 macrophages (data not
shown). Furthermore, we studied whether Rip2 is recruited to TLR
signalling complexes. 293T cells stably transfected with Flag-tagged
TLR2 and CD14 (Flag-TLR2/CD14 293T cells) were stimulated with
PGN, and association of TLR2 and endogenous Rip2 was examined
by immunoprecipitation using an anti-Flag monoclonal antibody.
Association of Rip2 with TLR2 was induced by PGN and peaked at
10 min after stimulation; the amount of associated Rip2 decreased
after 15 min, indicating that the recruitment of Rip2 to TLR
signalling complex is transient after TLR activation (Fig. 3b).
In addition to TLRs, increasing evidence implicates another
family of proteins in innate immune responses. The cytoplasmic
proteins collectively termed Nod, are characterized by the presence
of three motifs: a CARD, a nucleotide-binding domain (NBD) and a
leucine-rich repeat (LRR) region. These proteins have homology to
the NBD-LRR-like disease resistant proteins in plants14 – 16. An
increasing number of members of this family have been identified
(Nod1/CARD4, Nod2, DEFCAP/NAC, CARD12/Ipaf/CLAN), and
by analogy to the plant molecules these data imply that, like the TLR
family, Nod proteins are a diverse family of molecules designed to
detect pathogens in intracellular compartments—the LRR region of
members of both families probably confers pathogen specificity17,18.
In fact, Nod1 is activated on infection of Shigella flexneri in
epithelial cells19, and one NBD-LRR protein, NAIP, determines
susceptibility to Legionella pneumophila infection20. Also, it has
been demonstrated that Nod2 is mutated in patients susceptible to
Crohn’s disease and Blau syndrome18,21,22. In vitro studies have
revealed that Nod1 and Nod2 bind to Rip2 by means of a CARD–
CARD interaction15,16, suggesting that Rip2 may be involved in
signalling downstream of the Nod family proteins. To test this, we
generated Rip2-deficient embryonic fibroblasts and co-transfected
them with both Nod expression vectors and a NF-kB reporter
construct. NF-kB activation by Nod1/Nod2 expression was com-
pletely abolished in fibroblasts of RIP22/2 mice, and complementa-
tion of Rip22/2 fibroblasts with a Rip2 expression vector restored
these defects (Fig. 4). These results indicate that Rip2 is essential for
NF-kB activation by both Nod1 and Nod2. Together, these results
indicate that Rip2 is essential for signalling through both protein
families of the innate immune system, that is TLRs and Nod.
IL-1 and IL-18 receptors both have a TIR (Toll/IL1-receptor)
domain within the cytoplasmic tail, and therefore belong to the
same multigene family as the TLRs. We therefore tested whether
responses to IL-1 or IL-18 were altered in cells of Rip22/2 mice.
Under certain conditions, IL-1b is a potent co-stimulant to T cells
for their growth. We stimulated thymocytes with IL-1b, together
with IL-2 or a low dose of Concanavalin A (Con A). Thymocytes of
Rip22/2 mice showed reduced proliferation upon IL-1b stimulation
in both IL-2 and Con A co-stimulation (Fig. 5a). Embryonic
fibroblasts produce IL-6 upon stimulation with the cytokines
IL-1b or TNF-a. We found that embryonic fibroblasts of Rip22/2
mice were significantly impaired in their ability to produce IL-6
when stimulated with IL-1b, but not when stimulated with TNF-a,
suggesting that Rip2 is involved in IL-1- but not TNF-a-receptor
signalling (Fig. 5b).
We next investigated the IL-18 response in cells of Rip22/2 mice.
IFN-g production by natural killer (NK) cells upon IL-18 stimu-
lation was assessed using splenocytes of Rip22/2 mice. IFN-g
production was severely reduced in Rip22/2 cells by stimulation
with IL-18 (Fig. 5c). Surprisingly, IFN-g production upon stimu-
lation with IL-12 was also reduced. Co-stimulation of Rip22/2 cells
with IL-18 and Il-12 also resulted in reduced production of IFN-g
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Figure 3 Rip2 is required for optimal TLR signalling. a, Rip2 is upstream of multiple
signalling pathways, including NF-kB, JNK, p38 and ERK. Macrophages derived from
bone marrow of wild-type and Rip2-deficient mice were stimulated with LPS (10 ng ml21)
for indicated periods. Cell lysates were prepared and blotted with the indicated antibodies.
Ratios of phosphorylated and unphosphorylated proteins quantified by an image-analyser
are shown. These data are the mean of three independent experiments. b, Transient
recruitment of Rip2 to TLR signalling complexes. Flag-TLR2/CD14 293T cells were
stimulated with 10 mg ml21 PGN for the indicated times. Cell lysates were















































Figure 4 Rip2 is essential for activation of NF-kB by Nod1 and Nod2. Embryonic
fibroblasts from wild-type and Rip2-deficient mice were co-transfected with pcDNA3,
pcDNA3-IKKb, pcDNA3-Nod1DLRR, pcDNA3-Nod2 or pcDNA3-Rip2, pEF-BOS-b-gal
and pBVI-Luc reporter plasmids. The experiments were repeated at least three times with
equivalent results.
letters to nature
NATURE | VOL 416 | 14 MARCH 2002 | www.nature.com196 © 2002 Macmillan Magazines Ltd
(Fig. 5c). Furthermore, we examined IL-18 and IL-12 response
using differentiated effector CD4þTH1 cells. Similar to NK cells,
effector TH1 cells make copious amounts of IFN-g when stimulated
with IL-18 and IL-12 in the absence of T-cell receptor (TCR)
stimulation23. IFN-g production by Rip22/2 TH1 cells stimulated
with IL-18, IL-12 or a combination of IL-18 and IL-12, was severely
perturbed (Fig. 5d). These results suggest that Rip2 is involved in
signalling downstream of the TLR/IL-1 receptor family, and the
altered IL-12 response suggests that Rip2 may be involved in IL-12
signalling either directly or indirectly. IL-12 is one of the principal
cytokines regulating T-cell differentiation. We therefore analysed
T-cell differentiation of Rip22/2 T cells. CD4þ T cells were cultured
for 4 days under either TH1 or TH2 conditions, and re-stimulated
with plate-bound anti-CD3 antibodies for 24 h. IFN-g production
by TH1 cells of Rip2
2/2 mice was reduced, although IL-4 production
of Rip22/2 TH2 cells was not affected. These results suggest that
Rip2 has an important role in the differentiation of TH1 cells but not
TH2 cells.
Altered TCR signalling has a profound influence on TH1/TH2
differentiation24. We therefore examined the response of Rip22/2
T cells on TCR stimulation with anti-CD3 antibodies. CD4þ T cells
of Rip22/2 mice showed severely reduced proliferation upon anti-
CD3 stimulation in a dose- and time-dependent manner (Fig. 6a).
IL-2 production was reduced in Rip22/2 CD4þ T cells, and this
defect could not be rescued by co-stimulation with anti-CD28
(Fig. 6b). As Rip2 is involved in NF-kB activation1 – 4, and that
NF-kB activation is required for T-cell proliferation upon TCR
stimulation25,26, we analysed NF-kB activation in Rip22/2 T cells
upon anti-CD3 stimulation. Phosphorylation and degradation of
IkBa was assessed by western blotting, and was reduced in Rip22/2
T cells (Fig. 6c). In addition, NF-kB activation assessed by gel-shift
assay was also substantially reduced (Fig. 6d). Taken together, these
data indicated that Rip2 is required for optimal activation of NF-kB
and T-cell proliferation upon TCR stimulation. As inhibition of
NF-kB activation can cause TH1 deficiency in vivo
27, the TH1
deficiency in Rip22/2 T cells may be attributable, at least in part,
to altered TCR signalling and NF-kB activation.
Figure 5 Rip2 is required for optimal IL-1/IL-18 receptor signalling in NK cells and TH1
effector CD4 T cells. a, Proliferation of Rip22/2 thymocytes stimulated with IL-2
(2 ng ml21) or Con A (0.625 mg ml21) alone or together with IL-1b (10 ng ml21), and
cultured for indicated periods. Cells were pulsed with [3H]thymidine 8 h before collection.
b, IL-6 production by Rip22/2 embryonic fibroblasts stimulated with IL-1b (left,
10 ng ml21) or TNF-a (right, 10 ng ml21) for indicated periods. c, Production of IFN-g by
NK cells on stimulation with IL-18 and IL-12. Splenocytes from wild-type or Rip22/2 mice
were stimulated with IL-18 (10 ng ml21) or IL-12 (10 ng ml21) alone for 48 h, or with both
IL-18 (10 ng ml21) and IL-12 (1 ng ml21) for 24 h. d, Production of IFN-g by TH1 cells
stimulated with either IL-18 (10 ng ml21) or IL-12 (10 ng ml21) alone, or with both IL-18
and IL-12 for 24 h. e, TH1/TH2 differentiation of CD4
þ T cells in vitro. CD4þ T cells from
wild-type or Rip22/2 mice were stimulated with 10 mg ml21 of plate-bound anti-CD3,
and cultured for 4 days under TH1 conditions (3.5 ng ml
21 IL-12 and 2 mg ml21 anti-IL-4
antibody) or TH2 conditions (1,000 U ml
21 IL-4 and 1 mg ml21 anti-IFN-g antibody). After
washing, cells were counted and re-stimulated with 10 mg ml21 anti-CD3 and cultured
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Figure 6 Rip2 is required for optimal NF-kB activation, IL-2 production and T-cell
proliferation on TCR stimulation. a, Proliferation of Rip22/2 CD4þ T cells stimulated with
Concanavalin A (Con A, 2.5 mg ml21), PMA (40 ng ml21) plus ionomycin (0.5 mM) or anti-
CD3 at the indicated dose (96 h), or with 10 mg ml21 anti-CD3 for indicated periods in the
presence of irradiated T-cell-depleted splenocytes. b, IL-2 production by CD4þ T cells
stimulated with plate-coated anti-CD3 either in the absence or presence of anti-CD28
(2 mg ml21), or with Con A (2.5 mg ml21). c, Phosphorylation and degradation of IkBa in
splenic T cells stimulated with anti-CD3 (10 mg ml21), examined by western blotting.
d, NF-kB activation of splenic T cells stimulated with anti-CD3 with indicated dose for 8 h,
analysed by gel mobility shift assay. Experiments in a and b were performed in triplicates
and were repeated three times with equivalent results.
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Our results indicate that Rip2 is required for signalling through
both TLRs and Nod protein family members, which are central
components of the innate immune system. We also show that Rip2
is required for appropriate TCR signalling. Therefore, Rip2 is a
unique kinase capable of integrating signals emanating from both
the innate as well as the adaptive immune systems. In fact, a notable
feature of Rip2 deficiency is that it reveals defects in signalling from
various immune receptors. There are three conceivable mechanistic
explanations for this. The first is that Rip2 is a direct downstream
signalling molecule of each receptor. Second, it is possible that Rip2
always receives signals from Nod proteins, and that perhaps differ-
ent Nod proteins are the common element downstream of these
different innate and adaptive immune receptor systems, and
upstream of Rip2. The third possibility is that some receptors are
dependent on Rip2 via Nod proteins for signalling, and others are
not. Studies involving Nod-deficient mice should help to resolve
this mechanistic issue. A
Methods
Generation of Rip2-deficient mice
A murine partial complementary DNA that codes for Rip2 was obtained by polymerase
chain reaction, using mouse heart first-strand cDNA (Clontech) as the template and a
specific primer based on GenBank accession number AA655189 and a primer based on the
human RIP2 sequence. A 129SV/J genomic library (Stratagene) was screened with the
murine Rip2 cDNA, and two phage carrying overlapping genomic clones encompassing
Rip2 were isolated. A targeting vector was designed to replace a 4.0-kilobase genomic
fragment containing the second and third exons coding for the active site aspartate residue
with the loxP-flanked neor gene expression cassette. The targeting vector was linearized
with NotI and electroporated into W9.5 embyronic stem cells. Clones resistant to G418
and gancyclovir were selected, and homologous recombination (6 out of 135 clones) was
confirmed by Southern blotting. Three clones homologous for the targeted mutation were
injected into C57BL/6 blastocysts, which were subsequently transferred into
pseudopregnant foster mother mice.
Plasmids and reagents
The expression vectors pcDNA3-IKKb, pcDNA3-Myc-Rip2, pcDNA3-Nod1-Flag,
pcDNA3-Nod2-Flag, pEF1-BOS-b-gal and pBVI-Luc were described previously16.
Lipopolysacchride (LPS) from Salmonella abortus equi and lipoteichoic acid (LTA) from
Staphylococcus aureus were purchased from Sigma. Peptidoglycan (PGN) from S. aureus
was from Fluka. Poly(IC) was from Amersham Pharmacia Biotech. Phosphorothioate-
modified CpG oligonucleotide DNA (TCCATGACGTTCCTGACGTT) was synthesized in
the Howard Hughes Medical Institute Biopolymer and W. M. Keck Biotechnology
Resource Laboratory in Yale University. Human IL-1b and mouse TNF-a were from R&D
mouse IL-18 was from MBL; mouse IL-12 was from Genetics Institute; mouse IL-4 was
from PharMingen; and anti-CD3, anti-IL-4 or anti-IFN-g were purified from
supernatants of 2C11, 11B11 or XMG hybridoma, respectively.
Culture of bone-marrow-derived macrophages
Macrophages derived from bone marrow were prepared as described28. Cells were
collected with cold DPBS, washed, re-suspended in DMEM, supplemented with 10% fetal
calf serum, and used at a density of 2 £ 105 ml21 in the experiments. Cells were left
untreated for at least 4 h at 37 8C in 10% CO2 before further handling.
Listeria infection of macrophages
The cells were cultured without antibiotics, and L. monocytogenes (American Type Culture
Collection strain 43251) was added at a multiplicity of infection (MOI) of 50. After
incubation for 30 min, extracellular bacteria were removed by washing three times with
DPBS. To prevent reinfection, we cultured the cells in medium containing gentamicin
sulphate (50 mg ml21, Gibco BRL)
Measurement of cytokine production
Macrophages derived from bone marrow were cultured with the indicated concentration
of LPS, LTA, PGN or CpG DNA for 6 h. Embryonic fibroblasts were cultured with
poly(IC), LPS, IL-1b or TNF-a at the indicated concentration for the indicated periods.
The concentration of IL-6, TNF-a and IP10 in culture supernatants was measured by
ELISA.
Proliferation assays
We stimulated thymocytes with IL-2 (2 ng ml21) or Con A (0.625 mg/ml), in the presence
or absence of IL-1b (10 ng ml21). Purified CD4þ T cells were stimulated with anti-CD3
(2C11) in the presence of T-cell-depleted irradiated splenocytes. Cells were pulsed with
[3H]thymidine for 8 h, and its incorporation was measured with a b-plate counter
(Wallac).
Cytokine production by NK cells and T cells
TH1/TH2 differentiated cells were washed and re-stimulated with 10 mg ml
21 anti-CD3,
and cultured for 24 h. IFN-g and IL-4 in the supernatant was measured. Total splenocytes
and TH1 cells were stimulated with IL-18 (10 ng ml
21), IL-12 (10 ng ml21) or a
combination of both. We measured the concentration of IFN-g and IL-4 by ELISA. For IL-
2 production, purified CD4þ T cells were stimulated with plate-bound anti-CD3 in the
presence or absence of anti-CD28 (2 mg ml21) at the indicated concentration for 24 h, and
the level of IL-2 in the supernatant was measured by ELISA.
NF-kB activation assay
NF-kB activation assays were carried out as described1.
Western blot analysis and immunoprecipitation
Cell lysis and blotting were carried out as described29. Membranes were blotted with
antibodies to Rip2 (Cayman), IkB, JNK, p38, ERK1/2 (phosphorylated and
unphosphorylated forms for each; Cell signaling), IRAK-1, TRAF6 (both Santa Cruz), and
MyD88 (StressGen). We carried out immunoprecipitation as described29 using an anti-
Flag monoclonal antibody (Sigma).
Northern blot analysis
Macrophages derived from bone marrow were stimulated with 10 ng ml21 LPS for the
indicated periods. Preparation of total RNA samples and northern blot analysis were
performed as described previously29.
T-cell stimulation for NF-kB activation
Purified splenic T cells were incubated with anti-CD3 antibodies at the indicated
concentration for 30 min on ice. After washing, cells were incubated with anti-hamster
immunoglobulin-g antibody (100 mg ml21; Vector) at 37 8C for the indicated periods.
Cytoplasmic and nuclear extracts were used for western blot analysis and gel mobility shift
assay using a [32P]dCTP-labelled probe specific for NF-kB (5 0 -GGAGTTGAGGGGACT
TTCCCAGGC-3 0 ).
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The sense of taste provides animals with valuable information
about the nature and quality of food. Mammals can recognize and
respond to a diverse repertoire of chemical entities, including
sugars, salts, acids and a wide range of toxic substances1. Several
amino acids taste sweet or delicious (umami) to humans, and are
attractive to rodents and other animals2. This is noteworthy
because L-amino acids function as the building blocks of pro-
teins, as biosynthetic precursors of many biologically relevant
small molecules, and as metabolic fuel. Thus, having a taste
pathway dedicated to their detection probably had significant
evolutionary implications. Here we identify and characterize a
mammalian amino-acid taste receptor. This receptor, T1R1+3, is
a heteromer of the taste-specific T1R1 and T1R3 G-protein-
coupled receptors. We demonstrate that T1R1 and T1R3 combine
to function as a broadly tuned L-amino-acid sensor responding to
most of the 20 standard amino acids, but not to their D-enan-
tiomers or other compounds. We also show that sequence
differences in T1R receptors within and between species
(human and mouse) can significantly influence the selectivity
and specificity of taste responses.
T1Rs and T2Rs are two families of G-protein-coupled receptors
(GPCRs) selectively expressed in subsets of taste receptor cells3 – 11.
T2Rs are involved in bitter taste detection4,5, and T1R2 and T1R3
combine to function as a sweet taste receptor7. To identify taste
receptors involved in amino-acid detection, we used an expression
screening strategy similar to that used in the characterization of
bitter and sweet taste receptors. Candidate receptors were expressed
in human embryonic kidney (HEK) cells containing the Ga16 –GaZ
and Ga15 promiscuous G proteins
12,13, and assayed for stimulus-
evoked changes in intracellular calcium. In this system, receptor
activation leads to activation of phospholipase Cb (PLC-b) and
release of calcium from internal stores, which can be monitored at
the single-cell level using calcium-indicator dyes5,7,14.
Because T1R taste receptors are distantly related to GPCRs that
recognize the amino acids glutamate15 (metabotropic glutamate
receptors, mGluRs), GABA16 (g-aminobutyric acid; GABA-B recep-
tors) and arginine17 (the R5-24 receptor), we began by testing
members of the T1R family. Patterns of T1R expression define at
least three distinct cell types: cells co-expressing T1R2 and T1R3
(T1R2+3, a sweet receptor), cells co-expressing T1R1 and T1R3
(T1R1+3) and cells expressing T1R3 alone7. First, we assayed
responses of the T1R2+3 sweet taste receptor to all 20 standard
and various D-amino acids. Several D-amino acids that taste sweet
to humans, and are attractive to mice, trigger robust activation of
the T1R2+3 sweet taste receptor (Fig. 1a, b). However, none of the
tested L-amino acids activate this receptor.
Mouse T1R1 and T1R3 were transfected alone or in combination
and tested for stimulation by L-amino acids. Individual receptors
showed no responses. In contrast, T1R1 and T1R3 combine to
function as a broadly tuned L-amino-acid receptor, with most
amino acids that are perceived as sweet (for example, alanine,
glutamine, serine, threonine and glycine2) activating T1R1+3
(Fig. 1). The responses are strictly dependent on the combined
presence of T1R1 and T1R3, and are highly selective for L-amino
acids; D-amino acids and other natural and artificial sweeteners did
not activate the T1R1+3 receptor combination. These results sub-
stantiate T1R1+3 as a receptor for L-amino acids, and provide a
striking example of heteromeric GPCR receptors radically altering
their selectivity by a combinatorial arrangement of subunits.
If T1R1+3 functions as a major L-amino acid taste sensor in vivo,
we might expect its cell-based behaviour to recapitulate some of the
physiological properties of the in vivo receptor. Nerve recordings in
rats have shown that taste responses to L-amino acids are consider-
ably potentiated by purine nucleotides such as inosine monophos-
phate (IMP)18. To assay the effect of IMP, HEK cells expressing the
T1R1+3 receptor combination were stimulated with amino acids in
the presence or absence of IMP. Indeed, T1R1+3 responses to nearly
all L-amino acids were dramatically enhanced by low doses of IMP
(Figs 1 and 2a); this effect increased over a range of 0.1–10 mM
(Fig. 2b). However, IMP alone elicited no response, even at the
highest concentration tested in our assays, and it had no effect on
responses mediated by T1R2+3 (either to sweeteners or to L- and D-
amino acids; data not shown).
T1R1+3 is prominently expressed in fungiform taste buds7,
which are innervated by chorda tympani fibres. Therefore, we
stimulated mouse fungiform papillae at the front of the tongue
with various amino acids in the presence or absence of IMP, and
recorded tastant-induced spikes from the chorda tympani nerve. As
expected, nerve responses to L-amino acids were significantly
enhanced by IMP18 (Fig. 3). However, IMP had no significant effect
on responses to D-amino acids or to non-amino-acid stimuli.
Genetic studies of sweet tasting have identified a single principal
locus in mice influencing responses to several sweet substances (the
Sac locus19,20). Sac ‘taster’ mice are about fivefold more sensitive to
sucrose, saccharin and other sweeteners than Sac non-tasters. Sac
codes for T1R37 – 11,21. There are two amino-acid differences that
define taster and non-taster alleles7,9,10. One of these changes, I60T,
introduces a potential glycosylation site that was proposed to
eliminate receptor function by preventing receptor dimerization10.
This poses a conundrum because responses to L-amino acids are not
influenced by the Sac locus7,22 (and data not shown). Thus, if T1R3
functions as the common partner of the sweet and amino-acid
receptors, we reasoned that the T1R3 non-taster allele must selec-
tively affect the T1R2+3 combination.
We examined the effect of the Sac non-taster allele on T1R1 and
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